Clinical Trials
6 trialsNCT07005336 2026-01-30
A Study to Compare Uliledlimab Combined With Sintilimab and Chemotherapy Versus Sintilimab Combined With Chemotherapy in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Non-small Cell Lung Cancer
TJ Biopharma Co., Ltd.
Phase 2 Active not recruiting
NCT05116462 2025-06-26
Neoadjuvant and Adjuvant Therapy Studies of Sindilizumab in Resectable Lung Cancer
Innovent Biologics (Suzhou) Co. Ltd.
Phase 3 Active not recruiting
NCT04836728 2025-03-13
CCICC-002b
Tianjin Medical University Cancer Institute and Hospital
Phase 2 Active not recruiting
NCT05400070 2024-10-18
Neoadjuvant PD-1 Inhibitor (Sintilimab), Anlotinib Combined With Chemotherapy in Resectable Stage IIA-IIIB NSCLC
Tang-Du Hospital
Phase 2 Active not recruiting
NCT05244213 2024-07-08
NEOTIDE
Guangdong Provincial People's Hospital
Phase 2 Active not recruiting
NCT04326153 2024-02-01
Neo-Pre-IC
The First Hospital of Jilin University
Phase 2 Active not recruiting